Aktivitas Anti-Mycobacterium tuberculosis Kombinasi (-)-Epigallocatechin-Gallate (EGCG) dan Obat Antituberkulosis Lini Pertama

  • Anggita Mirzautika Balai Penelitian dan Pengembangan Kesehatan Magelang, Indonesia
  • Isnaeni Isnaeni Faculty of Pharmacy, Airlangga University, Surabaya
  • Djoko Agus Purwanto Faculty of Pharmacy, Airlangga University, Surabaya
Keywords: (-)-Epigallocatechin-gallate, First-line antituberculosis drugs, Anti-Mycobacterium tuberculosis, Synergism effect

Abstract

Tuberculosis is a global health problem, and there is even an increase in cases of multidrug-resistant tuberculosis in the world. Therefore, research is needed that can find new anti-tuberculosis drugs (OAT) that are more effective for tuberculosis treatment. In this study, the effect of (-)-epigallocatechin-gallate (EGCG) of tea leaves (Camellia sinensis) combined with the first-line OAT will be observed, in order to find out whether EGCG has anti-tuberculosis activity and can increase the potential of first-line OAT in-vitro. The anti-tuberculosis activity of EGCG was determined by broth dilution method using Middlebrook 7H9 media at concentration of 50, 100, 150, dan 200 ppm, then the potential of first-line OAT before and after combined with the EGCG was observed. The results showed that the activity of EGCG at concentration 50 ppm and 100 ppm could inhibit the Mycobacterium tuberculosis growth by 80%, at concentration 150 ppm by 90%, and at concentration 200 ppm by 100%. First-line OAT activity before combined with EGCG was ≥ 90% at 5 ppm rifampicin, 0.5 ppm isoniazid, 50 ppm pyrazinamide, and 5 ppm ethambutol. Whereas after combined with EGCG, the potential of each drug increased, marked by anti-tuberculosis activity achieved ≥ 90% at lower concentrations, i.e. rifampicin 0.5 ppm, isoniazid 0.25 ppm, pyrazinamide 20 ppm, and ethambutol 2 ppm. These results indicated that the potential of each first-line OAT increases after being combined with EGCG, and EGCG has potentiation effect when combined with those drugs. In conclusion, EGCG can increase the first-line OAT activity

References

Global Tuberculosis Report 2013. Geneva: World Health Organization; 2013.

Kementerian Kesehatan Republik Indonesia. Situasi TBC di Indonesia. Diperoleh dari: https://www.tbindonesia.or.id/page/view/11/situasi-tbc-di-indonesia [Diakses 2019 Oktober 15].

World Health Organization. Multidrug-resistant tuberculosis (MDR-TB) October 2013 Update. Diperoleh dari: www.who.int/tb/challenges/mdr [Diakses 2013 November 27].

Faustini A, Hall AJ, Perucci CA. Risk factors for multidrug resistant tuberculosis in Europe: a systematic review. Thorax. 2006 Oct;61:158-163.

Mulu W, Mekonnen D, Yimer M, Admassu A, Abera B. Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State. African Health Sciences. 2015 June;15(2):368-377.

Koech KR, Wachira FN, Ngure RM, Wanyoko JK, Bii CC, Karori SM, et al.Antimicrobial, synergistic and antioxidant activities of tea polyphenols. In: A. Méndez-Vilas, Ed.Microbial pathogens and strategies for combating them: science, technology and education. Badajoz: Formatex Research Center; 2013. p. 971-981.

Anand PK, Kaul D, Sharma M. Green tea polyphenol inhibits Mycobacterium tuberculosis survival within human macrophages. The International Journal of Biochemistry & Cell Biology. 2006 Nov;38:600-609.

Das S, Tanwar J, Hameed S, Fatima Z. Antimicrobial potential of epigallocatechin-3-gallate(EGCG): a green tea polyphenol. Journal of Biochemical and Pharmacological Research. 2014 September;2(3):167-174.

Fatima Z, Hameed S, Islam N. Epigallocatechin-3-gallate(EGCG), a green tea polyphenol suppresses bacilli-inducedaugmented expression of Mycobacterium tuberculosis 85Band proinflammatory TNF-α in human monocytes. International Journal of Scientific and Research Publications. 2012 February;2(2):1-6.

Fatima Z, Hameed S, Islam N. Green tea polyphenol (EGCG) is a better inhibitor of TNF-α and MTB 85B antigen in human monocytes than known antioxidants and antibiotics. The Journal of Infectious Diseases. 2013 March;112:131-137.

Peñuelas-Urquides K, Villarreal-Treviño L, Silva-Ramírez B, Rivadeneyra-Espinoza L, Said-Fernández S, Bermúdez de León M. Measuring of Mycobacterium tuberculosis growth. A correlation of the optical measurements with colony forming units. Brazilian Journal of Microbiology. 2013 Mei;44(1):287-290.

Chen C, Song F, Wang Q, Abdel-Mageed WM, Guo H, Fu C, et al. A marine-derived Streptomyces sp. MS449 produces highyield of actinomycin X2 and actinomycin D with potent anti-tuberculosis activity. Applied Microbiology and Biotechnology. 2012 April;95:919-927.

Klancnik A, Piskernik S, Jersek B, Mozina SS. Evaluation of diffusion and dilution methods to determine the antibacterial activity of plant extracts. Journal of Microbiological Methods. 2010 May;81(2):121-126.

Gupta R, Thakur B, Singh P, Singh HB, Sharma VD, Katoch VM, et al. Anti-tuberculosis activity of selected medicinal plants against multidrug resistant Mycobacterium tuberculosis isolates. Indian Journal of Medical Research. 2010 June;131:809-813.

Sulistia GG. Farmakologi dan Terapi, Edisi 5. Jakarta: Balai Penerbit FKUI; 2007.

Silva PEAD, Palomino JC. Molecular basis and mechanisms of drug resistance in M. tuberculosis: classical and new drugs. Journal of Antimicrobial Chemotherapy. 2011 May;66:1417-1430.

Published
2020-02-24
How to Cite
1.
Mirzautika A, Isnaeni I, Purwanto D. Aktivitas Anti-Mycobacterium tuberculosis Kombinasi (-)-Epigallocatechin-Gallate (EGCG) dan Obat Antituberkulosis Lini Pertama. jki [Internet]. 24Feb.2020 [cited 14Jul.2020];10(1):59-6. Available from: https://ejournal2.litbang.kemkes.go.id/index.php/jki/article/view/1726